Hamlet Protein, multinational producer of soy protein specialties for young animals, aims for continuous growth in the U.S.. The company has made significant investments in production capacity in its Findlay, Ohio facilities in recent years and is now ready to increase its market share in the U.S. and Canada. To help drive that growth, Hamlet Protein announced the appointment of Grady Fain as vice president of sales and marketing for the NCA region.

Grady Fain has a long track record in the animal feed industry. He started his career in the Wayne feed division of Continental Grain Company, then joined Feed Flavors Inc., which eventually became Nutriad Inc., and most recently transitioned to Adisseo.

Fain said that “over the course of my career I have always focused on working with companies that bring true value to customers. Hamlet Protein has a high-quality product portfolio with a proven track record in markets across the world. I am particularly excited about the value proposition into young animals and the approach into AGP free diets.”

The U.S. continues to be the second largest feed producer in the world, behind China. Hamlet Protein opened its U.S. production, and recently completed a major investment to increase capacity under patented technology. Hamlet Protein CEO, Erik Visser, said that “the U.S. animal feed market is expected to grow at a CAGR of 2.4% from $75 Billion in 2018 to $85 Billion in 2024. Not only will the total feed volume grow, but the need to produce more efficiently will take center stage. Also, consumers will drive the reduction of antibiotics in feed, which is where Hamlet Protein can play a role. We are optimistic about our potential in the North American market, considering our track record in other markets around the world.”